Strategic partnership Nanion collaborates with other ion channel and drug discovery players, signaling openness to alliances, services, and joint events. This presents sales opportunities through channel partnerships, co-marketing, and bundled offerings with complementary providers.

Expanding product line With automated patch clamp systems plus in vitro platforms for transporters, bilayer recordings, contractility, and cell analytics, Nanion targets a broad research space. This creates cross-sell potential to existing customers migrating into newer formats or requiring broader assay capabilities.

HTS leadership Recent launches of high-throughput giga-ohm seal platforms and 384-well solutions indicate a focus on scalable, reliable ion channel screening. Sales conversations can emphasize throughput, reliability, and ease of integration into existing HTS workflows.

Global reach in biotech Based in Munich with a global customer base in biotechnology research and drug discovery, Nanion serves mid-sized to larger labs. This suggests targeting regional distributors, regional pharma accounts, and academic愿iversities expanding electrophysiology programs.

Support and services Nanion highlights decades of scientific support and best-practice know-how. There is an opportunity to upsell services, training, and assay development outsourcing to accelerate customers’ research timelines.